| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |